Free Trial

AngioDynamics (ANGO) Stock Price, News & Analysis

AngioDynamics logo
$9.39 -0.13 (-1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$9.38 -0.01 (-0.11%)
As of 06:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About AngioDynamics Stock (NASDAQ:ANGO)

Key Stats

Today's Range
$9.33
$9.67
50-Day Range
$8.63
$11.14
52-Week Range
$5.47
$13.50
Volume
508,291 shs
Average Volume
583,350 shs
Market Capitalization
$381.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Buy

Company Overview

AngioDynamics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

ANGO MarketRank™: 

AngioDynamics scored higher than 80% of companies evaluated by MarketBeat, and ranked 235th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AngioDynamics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AngioDynamics has only been the subject of 1 research reports in the past 90 days.

  • Read more about AngioDynamics' stock forecast and price target.
  • Earnings Growth

    Earnings for AngioDynamics are expected to grow in the coming year, from ($0.37) to ($0.26) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AngioDynamics is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AngioDynamics is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AngioDynamics has a P/B Ratio of 1.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about AngioDynamics' valuation and earnings.
  • Percentage of Shares Shorted

    6.61% of the float of AngioDynamics has been sold short.
  • Short Interest Ratio / Days to Cover

    AngioDynamics has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in AngioDynamics has recently increased by 31.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    AngioDynamics does not currently pay a dividend.

  • Dividend Growth

    AngioDynamics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.61% of the float of AngioDynamics has been sold short.
  • Short Interest Ratio / Days to Cover

    AngioDynamics has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in AngioDynamics has recently increased by 31.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    AngioDynamics has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for AngioDynamics this week, compared to 3 articles on an average week.
  • Search Interest

    Only 4 people have searched for ANGO on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AngioDynamics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.40% of the stock of AngioDynamics is held by insiders.

  • Percentage Held by Institutions

    89.43% of the stock of AngioDynamics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AngioDynamics' insider trading history.
Receive ANGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter.

ANGO Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
AngioDynamics reports Q3 adjusted EPS (8c), consensus (13c)
See More Headlines

ANGO Stock Analysis - Frequently Asked Questions

AngioDynamics' stock was trading at $9.16 on January 1st, 2025. Since then, ANGO stock has increased by 2.5% and is now trading at $9.39.
View the best growth stocks for 2025 here
.

AngioDynamics, Inc. (NASDAQ:ANGO) announced its quarterly earnings data on Wednesday, April, 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.13) by $0.16. The business's revenue was down 4.3% compared to the same quarter last year.
Read the conference call transcript
.

AngioDynamics subsidiaries include these companies: Eximo Medical Ltd., RadiaDyne LLC, Clinical Devices, Vortex Medical, Navilyst Medical Inc., FlowMedica, Oncovionic, and more.

Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AngioDynamics investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
4/02/2025
Today
7/02/2025
Next Earnings (Estimated)
7/15/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ANGO
Employees
760
Year Founded
1988

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$16.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+49.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$184.35 million
Pretax Margin
-14.85%

Debt

Sales & Book Value

Annual Sales
$303.91 million
Cash Flow
$4.06 per share
Price / Cash Flow
2.31
Book Value
$5.13 per share
Price / Book
1.83

Miscellaneous

Free Float
38,414,000
Market Cap
$380.72 million
Optionable
Optionable
Beta
0.60

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:ANGO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners